RHHBY to Invest $1.25B to Boost Manufacturing Footprint in US

Less than a month after announcing a $50 billion investment in its U.S. operations over the next five years, Swiss pharma giant Roche (RHHBY) has started rolling out the details of its plans.RHHBY unveiled plans to invest over $700 million in a new 700,000-square-foot, state-of-the-art drug manufacturing facility in Holly Springs, NC. Through this new plant, the company intends to support its pipeline of next-generation obesity drugs for Genentech, a member of the Roche group.Roche expects the project to ge ...